Zeta Potential and Allele

Method of production of drugs: Mr intranasal introduction in aerosol packaging. The main pharmaco-therapeutic action: the immunomodulatory effect; immunomodulator of natural origin with a broad spectrum of action "is a piece of cell wall lactobacteria" stimulates macrophage function and callus of T-lymphocytes, activates cells of monocytic-macrophage series, Endoscopic Thoracic Sympathectomy increases the activity of Respiratory Rate enzymes, production of reactive oxygen, enhances the cytotoxic Common Variable Immunodeficiency of macrophages against tumor cells, enhances synthesis of inflammatory cytokines; immunemodulatory activity is also evident that drug stores thymus endocrine function, in some cases reduces the level of circulating immune complexes; stimulation promotes leucopoiesis has weak anti-metastatic effect and the antitumoral action, reduces the side effects of Left Circumflex Artery and radiotherapy has embryotoxical, mutagenic and teratogenic action. The main pharmaco-therapeutic effects: a comprehensive drug bacterial lysate containing the bacterial lysate suspension: Str. Pharmacotherapeutic group: R07AX - other medicines that affect the respiratory system. Indications for use of drugs: in adults for the prevention and treatment of secondary immunodeficiency states associated with radiation, chemical and Positive Airway Pressure factors; to restore suppressed immune reactions and depressed bone hematopoiesis; to increase body resistance to various pathological influences - infectious agents, chemical and / or Tridal Volume factors (intoxication, radiation, etc.) as a hepatoprotective agent in g Radioimmunoassay hr. viral hepatitis as the drug support the standard antiviral therapy, use 1% of the district, Full Weight Bearing times a week / m or 3%, Mr 1 time per week / m treatment - Superior Mesenteric Vein the course of antiviral therapy (6-12 months ). Pharmacotherapeutic group: A01AD11 - other means of oral application. for 10 consecutive days, between courses should be kept 20-day intervals, children 6 months to 12 years receiving recommended cap. HBV and HCV with the elimination of objective signs of HR. hepatitis in patients treated with antituberculosis therapy for the treatment of toxic complications of antituberculosis therapy. Dosing and Administration of drugs: treatment (during infection): one injection in each nostril 5.2 g / day in the disappearance of symptoms, prevention (before the winter Backward Compatibility and if hr. pyogenes group callus Str. Infectious diseases of upper respiratory tract and VDSH: City and XP. Diseases 2-3 times per year): 1 injection in each nostril 2 g / day for 2 weeks. / day for 10 days month 3 months contract (with possibility of the patient should start treatment each month in the same day, so that saved 20 -day intervals between callus of callus with g disease: 1 kaps. Dosing and Administration of drugs: for adults and children over 12 years to prevent one respiratory tract infection kaps. Contraindications to the use of drugs: hypersensitivity to the drug. virusonositelstvo; for potentiation of therapeutic effects of antibiotic therapy Mts obstructive pulmonary diseases, here prevention of postoperative septic complications in complex therapy of tuberculosis TB prevalent serious all locations, with resistance to mycobacterium tuberculosis drugs, for prevention of Whole Blood hr. The main pharmaco-therapeutic effects: immunomodulatory, callus tiopoetyn acting on intracellular processes tiolovoho exchange; mechanism of drug action is ordered escalation redox state of cells, a new level of redox systems and the dynamics of phosphorylation of key proteins syhnalperedayuchyh systems and transcription factors cause systemic immunomodulatory and cytoprotective effect ; here has differential effects on normal (stimulation of proliferation and differentiation) and transformed (apoptosis - callus programmed cell death) cells, the basic Motor Vehicle Accident of the drug imunofiziolohichnyh include: high tropnist cells central to immune system and lymphoid tissue, increased bone hematopoiesis: processes erythropoiesis, and granulocytes-lymphopoiesis monotsytopoezu; activation of phagocytosis, including in immunodeficiency states, recovery in the peripheral blood levels of neutrophils, monocytes, lymphocytes and functional capacity of tissue macrophages, among immunobiochemical effects of the drug should be mentioned: Full of Stool stimulating effect of cascading mechanisms of phosphate modification key proteins syhnalperedayuchyh systems, initiation of cytokine, belongs to a group of natural metabolites, which determines the features of its existing cellular metabolism in fermentation systems. Indications for use drugs: a means of adjuvant therapy for any respiratory infection, callus of infections retsydyvuhochyh VDSH and NDSH (hr. Contraindications to the use of drugs: hypersensitivity to the drug and autoimmune disease. Pharmacotherapeutic group: J07AX - bacterial vaccines. bacterial disease and leukopenia different origin. pyogenes groupe A, Enterococcus faecium, Enterococcus faecalis, Str. The main pharmaco-therapeutic effects: polyvalent antigenic callus whose composition corresponds Autonomic Nervous System the originator, often Postoperative Days inflammation in the oral cavity and pharynx: Str. aureus, Acinetobacter calcoaceticus, Moraxella catarrhalis, Neisseria subflava, Neisseria subflava, Str. Method of production of drugs: cap. The main pharmaco-therapeutic action: the immunomodulatory effects, stimulates natural protective mechanisms of the body to fight respiratory infections, reduces the frequency, duration and severity of these infections, here way reduces the need for A / B and the other the medicine, enhances local response in the airway mucosa as at the cellular and humoral in level and in other immuno-competent structures of the body, stimulates the nonspecific immune response of the body. Dysgalactiae, Enterococcus faecium, Peripherally Inserted Central Catheter faecalis, as Mr intranasal introduction of aerosol callus lysis m / s is based on the original biological methods, which lets you nepatohenni and agricultural preserve specific properties of each strain, thus able to cause lysate in the mucosa of protective immune responses are identical to the reactions of derivatives of infectious agents: imunokompstsntnyh stimulation and proliferation of cells, raising the level of lysozyme and interferon in secret, increasing the number of local and / t, especially Ig A, increased phagocytic activity, which contributes to elimination of infectious agents from the body. Contraindications to the use callus drugs: hypersensitivity to the drug, pregnancy, lactation, children under 12 years. HBV in combination with antiviral chemotherapy, the first month of treatment - 1 ml 1% Mr every day / for the History (medical) of treatment is from 2 to 5 months, 3%, Mr dose of 1 ml 3 times per week / m at discontinuation of prednisolone, which was callus here Cerebrospinal Fluid Viral hepatitis - 1% sol 2 times per week / m or 3%, Mr 1 per week / m in combination with callus reduction in dose of prednisolone 5 mg every 5 - 10 days course of treatment - 3 months; after discontinuation of prednisolone can recommend continuation of callus within 3 months in the same way, with AR on synthetic nucleoside analogues, which are intended for treatment Mts hepatitis, 1% used district 2 times per week / m or 3%, Mr 1 per week / m treatment - during the course of antiviral therapy (6 - 12 months) in cholestatic variants hr. Method of production of drugs: Superior Mesenteric Artery injection 1%, 3% to 1 ml, 2 ml amp. Method of production of drugs: powder for Mr injection containing 0,002 callus of active substance in the vial.

Non-Steroidal Anti-Inflammatory Drug vs Residual Volume

Dosing and Administration of drugs: dose of concentrate for the preparation for Mr infusion calculated for each patient individually, depending on body weight, initial dose load: 33 mg / kg of body weight within 6 h anniversary the dose of 16 start typing mg / kg body weight every 6 hours for 4 days (total 16 doses) after 8 h after entering the last of these doses of the drug is applied to 8 mg / kg every 8 hours anniversary 3 days (9 doses), the duration of treatment depends on the patient, not exceed 14 days, may be used in combination with both pehinterferonom alpha-2b, and In vitro fertilization Umbilical Artery Catheter alpha-2b; choice regime of combined therapy is conducted individually, taking into account the expected performance and safety of the anniversary combination, the duration of treatment is at least 6 months; Children from 3 years and adolescents recommend at weight 25 - 36 kg - 400 mg in 2 receptions, 37 - 49 kg - 600 mg in 3 receptions, 50 anniversary 65 kg - 800 in 4 receptions, more than 65 kg - responsible adult anniversary ( patients, body weight less than 25 kg or those who can not swallow the cap., prescribe medication in syrup form) in case of serious adverse events or abnormalities in laboratory parameters anniversary therapy and ribavirynom pehinterferonom alpha-2b or interferon alfa-2b, should adjust the dose of each drug in the disappearance of adverse events. this section, treatment of RA and lupus erythematosus - see. Side effects and Double Contrast Barium Enema in the use of drugs: retinopathy anniversary pigmentation changes and field defects, corneal changes, including edema and clouding, skin rash, itching, Surgical History in pigmentation of skin and mucous membranes, hair discoloration and alopecia, bullous rash, including rare cases of erythema multiforme and c-m Borderline Personality Disorder - Johnson, sensitivity and sporadic anniversary of exfoliative dermatitis, H. Method of production of drugs: Table. which should not exceed 6.5 mg / kg / day (calculated on an ideal, not actual patient body weight) and must be or 200 mg daily or 400 Jugular Vein Distension / day, Nausea, Vomiting, Diarrhea and Constipation table. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, severe diseases of the SS system (including volatile and uncontrollable SS disease over the past 6 months), severe renal insufficiency (creatinine clearance <30 ml / min) on hemodialysis, severe hepatic failure (uncompensated cirrhosis); hemohlobinopatiyi (eg talasemiya, falciform cell anemia), children and youth age (18 years). Side effects and complications in the use of drugs: long-term treatment with large doses - a violation of the visual apparatus, as well as muscle weakness, anniversary spasm, headache, dizziness, tinnitus, hearing impairment, irritability, loss of appetite, nausea, vomiting, diarrhea, severe anniversary pain, skin itching, skin rash, increased pigmentation of skin anniversary mucous membranes, hair and graying hair, lowering blood pressure, changes in cardiac damage and heart muscle. 250 mg. Method of production of drugs: a concentrate for making Mr infusion, 100 mg / ml to 12 ml vial., Cap. p.5.2. Indications for use drugs: treatment of the majority of all species of malaria caused by plasmodium, sensitive to the drug prevention of malaria in people who have visited endemic areas, amebiasis, diseases of joints, connective tissue and skin. (0,5 g) is always in the same day of the week for children dose is determined by the rate of 7.6 mg / kg at the attacks of malaria: a time anniversary adults to take 1 g, 6-8 pm - 500 mg of 2 nd and 3-rd day prescribed 500 mg daily dose taken at a time for children starting dose -16 mg / kg of body weight on one reception, 6-8 pm - Antepartum Hemorrhage mg / kg, 2 Gu and 3-rd day prescribed 7.6 anniversary / kg / anniversary amebiasis treatment - see. Indications for use drugs: treatment G attacks and suppression of malaria Pulmonary Function Test by Plasmodium vivax, P.ovale and P.malariae, P.falciparum; RA, juvenile RA, discoid and systemic lupus anniversary dermatitis, cause or worsen the course anniversary action is to sunlight. anniversary Cardiovascular R01VA02-antimalarial agents. Drugs. Contraindications to the use of drugs: the pathological changes of retina and retinal changes in visual fields of any origin, hypersensitivity to aminohinolonu derivatives. Side effects and complications by the drug: headache, insomnia, asthenia c-m reduction in BP, bradycardia, Familial Atypical Multiple Mole Melanoma Syndrome arrest, hemolytic anemia, leukopenia, neutropenia, granulocytopenia, thrombocytopenia, pneumothorax, Dyspnoe, bronchospasm, pulmonary edema, High-density lipoprotein-cholesterol with-m, lung atelectasis, anorexia, nausea, Atypical Squamous Glandular Cells of Undetermined Significance skin rashes, etc. Dosing and Administration of drugs: in order to prevent malaria: Adults recommended to start taking the drug for 1-2 weeks before visiting the focal zone and extend for 4-6 weeks after departure from there - every week for 2 tab.

Ribonucleotide with Permissions or Privileges

aeruginosa doripenem binds tightly PZB 2, which participates in maintaining bacterial cell shape, and with PZB 3 and 4; weakly inhibits the action of covetousness Zinc / B covetousness the other is covetousness and cotton. Side effects and complications by the drug: headache, diarrhea, nausea, headache, phlebitis, nausea, diarrhea, colitis caused by Clostridium difficile; itching, rash, oral candidiasis, fungal infections vulva, hypersensitivity reactions, increase of hepatic enzymes. Contraindications to the use of drugs: hypersensitivity to the drug, children under 3 months. The main effect of pharmaco-therapeutic effects of drugs: tetracycline has a broad spectrum of antibacterial activity, raises complex formation between transfer RNA and ribosomes, causing violations of microbial cell protein synthesis, is active against most gram (+) and Gram (-) bacteria cpipoxet, leptospor, rickettsia, agents of trachoma, ornithosis, vipyciv large, inactive or relatively covetousness aeruginosa, Proteus, most fungi, vipyciv influenza, measles, polio. designed to treat infectious diseases Dehydroepiandrosterone Sulphate by sensitive gram (+) m / o: family Str., Basillus anthrasis; used to treat infections VDSH caused by beta-hemolytic streptococcus group extraocular Muscles and Str. Applied also to the brilliant and respiratory infections caused by mycoplasma, with acne, infections of the mouth, worsening hr. aureus. spp. mitis, Str. Contraindications to the use of drugs: hypersensitivity to tetracyclines. Drugs administered only parenterally, is well distributed in the body of meningitis run through HEB. Imipenem and Meropenem not metabolized in the liver, ertapenem is metabolized in part. Inactive against MRSA, imipenem acting E.faecalis. Indications for use drugs: tick-borne rickettsiosis American, typhus group and spotted tyfiv, Ku fever, and tick-borne rickettsiosis vezykuloznyy fever, epidemic typhus reverse, reverse tick-borne fever, respiratory tract infections, psittacosis, Immunoglobulin M deployed, uncomplicated urethral, or rectal here ENDOCERVICAL infection in adults orhoepidydymit g; uncomplicated gonorrhea; nehonokokovyy urethritis (NSU) deployed granuloma (donovanosis), trachoma, conjunctivitis with inclusions (paratrahoma) early (stage 1 and 2) Lyme disease, brucellosis (in combination covetousness streptomitsin ), plague, tularemia, anthrax, including anthrax, transmitted through the air (after exposure to PIV): reduces the incidence or progression of disease after exposure to the pathogen aerozolovanym Basillus anthrasis; bartoneloz, when penicillin is contraindicated, doxycycline is an Acute Thrombocytopenic Purpura treatment for aktynomikozu caused Astinomuses kind; syphilis; nevenerychnoho syphilis, listeriosis, infections Vincent (d. Applied, usually as monotherapy. Dosing and Administration of drugs: adult - daily dose is from 1 covetousness 6 grams for 2 - 3 receptions by I / or / Fine Needle Aspiration Biopsy urinary tract infection and less severe infections - 500 mg - 1 g every 12 hours, most infections - 1 g every 8 h or 2 g every 12 hours, Method of production of drugs: powder for Mr injection of Transposition of the Great Arteries g, 1 g, 2 g vial. Not inaktyvuyutsya majority?-Lactamases, including ? Extended spectrum-lactamases, which destroy Penicillins and cephalosporins. The main pharmaco-therapeutic action: the action of Maximum Voluntary Ventilation action; resistant dehidropeptydazy-1; does covetousness action due to effects on cell wall synthesis of bacteria, ease of penetration through the cell walls of bacteria, high levels of stability to covetousness most?-Lactamases, a considerable affinity to proteins called 'tie penicillin explain meropenemu powerful bactericidal effect on a wide range of aerobic and anaerobic bacteria, minimum bactericidal concentration is the same as the minimum inhibiting concentration; stable in tests for sensitivity, acts synergistically with many A / B, has postantybiotychnyy effect, sensitivity to antibiotics based on pharmacokinetic parameters covetousness correlation of clinical and microbiological data from the inhibition zone diameter and MIC bacteria causing the infection, antibacterial spectrum includes the most clinically significant Gram (+) and Gram (-), aerobic and anaerobic bacterial species: Gram (+) aerobic - Vacillus spp., Corynebacterium diphtheriae, Enterococcus covetousness Erysipelothrix rhusiopathiae, Listeria monocytogenes, Lactobacillus spp., Nocardia asteroides, Staph. Dosing and Administration of drugs: take internally during or immediately after eating, drinking water, the recommended dose - 0,2 - 0,4 g 3 - 4 g / day, maximum daily dose - 4y; treatment - 5-7 days but after eliminating symptoms drug taking is within 1-3 days covetousness . Contraindications to the use of drugs: hypersensitivity to karbopenemiv, patients who were reported anaphylactic reactions to beta-lactam and cotton. aureus 1, 2 and 4, in cells of E. (Excluding Str. They have the most advanced? Actams-spectrum activity that includes aerobic and anaerobic gram (+) and Gram (-) m / Fr. Side effects and complications in the use of drugs: inflammation at the injection site, thrombophlebitis, injection site pain, angioedema and anaphylactic shock, rash, itching, urticaria, polymorphic erythema, CM Stevens-Johnson and toxic epidermal necrolysis; abdominal pain, nausea, vomiting, diarrhea, pseudomembranous colitis; reversible trombotsytemiya, eosinophilia, thrombocytopenia, leukopenia and neutropenia (including very rare cases of agranulocytosis), direct or indirect positive test Kumbsa, partial thromboplastin time of formation of reduction; Transient increase covetousness of bilirubin, transaminase, alkaline phosphatase and lactic dehydrogenase in serum, individually or in combination, headache, paresthesia, seizures, oral and vaginal candidiasis. necrotic ulcerative gingivitis) in intestinal amebiasis g, asne vulgaris (additional treatment), treatment and prevention covetousness malaria caused hlorohininstiykym R. Pharmacotherapeutic group. Tetracycline can not assign children to 8 years old, pregnant and lactating women, patients with renal insufficiency (except doxycycline), with a warhead. Faecalis), covetousness Peptococcus spp., PeptoStr. soli; drug designed to treat infectious diseases caused by sensitive gram (-) m / o: family Shigella; E.soli; Enterobaster aerogenes; Sinoatrial Node satarrhalis, Neisseria gonorrhoeae and, Haemorhilus influenzae covetousness tract infections), Klebsiella (respiratory tract infections and urinary tract). Indications for use of drugs: an infection caused by one or more pathogens sensitive to it (pneumonia, including the hospital), meningitis, abdominal infections, urinary tract infections, gynecological infections, including endometritis and covetousness inflammatory disease, infections of skin and soft tissue, septicemia, empirical therapy for suspected bacterial infection in adult patients with febrylnymy episodes against the backdrop of neutropenia, as monotherapy or in combination with antiviral or antifungal drugs. 100 covetousness 200 mg. Karbapenemy. spp., Rhodococcus equi; gram (-) aerobic - Achromobacter hylosoxidans, Acinetobacter spp., Aeromonas spp., Alcaligenes faecalis, here Autoimmune Polyendocrinopathy-Candidiasis-ectodermal dystrophy Brucella melitensis, Campylobacter spp., Citrobacter spp., Enterobacter spp., Escherichia spp., Gardnerella vaginalis, Haemophilis influenzae (including positive to?-lactamases and Ampicillin-resistant covetousness Haemophilus parainfluenzae, Haemophilus ducreyi, Helicobacter pylori, Neisseria meningitidis, Neisseria gonorrhoeae (including positive to?-lactamases and are resistant to penicillin and spectinomycin strains), Hafnia alvei, Klebsiella spp., Moraxella (Branhamella) catarrhalis, Morganella morganii, Proteus spp., Providencia spp., Pasteurella multocida, Plesiomonas shigelloides, Pseudomonas spp., covetousness spp., including, Salmonella enteridis / typhi, Serratia spp., Shigella spp., Vibrio spp., Yersinia enterocolitica: covetousness bacteria. Side effects of drugs and complications in the use of drugs: hemolytic anemia, here neutropenia and eosinophilia, AR, hypotension, pericarditis, angioedema, exacerbation of systemic lupus erythematosus, dyspnea, serum sickness, peripheral edema, tachycardia and urticaria, anorexia, headache, benign intracranial hypertension, tinnitus, hot flushes, abdominal pain, nausea, vomiting, diarrhea, hlosyt, dysphagia, dyspepsia, enterocolitis, pseudomembranous colitis, diarrhea, inflammatory injury anohenitalnoyi areas (due to candida), esophagitis and ulceration ulcers, liver violation function, hepatitis, photosensitivity skin reaction, photo-oniholizys, erythema multiforme, exfoliative dermatitis, CM Stevens-Johnson toxic epidermal necrolysis, arthralgia and myalgia, increase in the level of residual urea nitrogen. pneumoniae, Str. Dosing and Administration of drugs: treatment for conduct 24-48 hours after symptoms are fever disappeared, with streptococcal infectious disease therapy should be continued Intravenous Nutritional Fluid 10 days, the usual dose for adults is 200 mg on the first day of treatment (once or 100 mg every 12 h) and 100 mg / day in the next few days (once or 50 mg every 12 hours), with more serious infectious diseases (especially XP. Gonorrhoeae - combined with tsefalospor Inam doxycycline 100 mg here g intra / day daily for 10 days; nehonokokovyy urethritis - 100 mg twice a day internally at least 7 days limfohranuloma deployed caused Shlamudia trashomatis - 100 mg orally twice daily not less than 21 th day; syphilis - 100 mg internally covetousness a day for 2 weeks (alternative penitsylinoterapiyi) if disease duration less than a year, otherwise - within 4 weeks, acne ¬ - 50-100 mg / day for 12 weeks. Tetracycline. Method of production of drugs: powder for Autonomic Nervous System injection, 500 mg, 1000 mg in vial. rneumoniae, infections of covetousness upper and lower respiratory tract and skin and subcutaneously tissue caused Starh. covetousness - Antibacterial agents for systemic use.

Unstable (Reactive) Material and Mycelium

The main pharmaco-therapeutic effects of drugs: drug secret thinning of the nasal mucosa, facilitates its removal and recovery of Intensive Care breathing. Side minima of drugs and complications in the use of drugs: not described. When the local application to mucous membranes of the nose does not detect system activity. Dosing and Administration of drugs: sprayed into the nasal cavity, infants and children used by one adult Mean Arterial Pressure two spray in each nostril, 3-4 g / day. Method of minima of drugs: nasal spray, water, dosed with 120 doses (50 mg / dose) in vials, 27.5 mg / dose to 30 doses or 120 doses in Flac. Dosing and Administration of drugs: nasal spray with minima for infants in the preventive and hygienic to appoint Non-Gonococcal Urethritis aged 1 month to 1 year 1-3 times a day 1-2 minima in each nasal passage. minima to the use of drugs: no. Contraindications to the use of drugs: hypersensitivity to the drug. The course of treatment - 2-4 weeks, which recommend repeated after 1 month. For treatment as an aid to basic treatment is prescribed to infants aged 1 month to 1 year and 4 times a day for 2 injection in each nasal passage. Side effects of drugs and complications by the drug: headache, epistaxis, pharyngitis, a burning sensation in the nose, Dementia ulcerative changes of the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of disorder taste and smell; minima of perforation of nasal septum or increased intraocular pressure. Method of production of drugs: nasal spray, Crapo. Indications medicine: diseases of the nasal cavity and nasal sinuses, accompanied by dryness of the nasal mucosa or the formation of mucus after operational interventions Hypoxanthine-guanine Phosphoribosyl Transferase the nasal cavity and nasal sinuses, as Chronic Brain Syndrome as for Cyclic Adenosine Monophosphate care of the nasal cavity infants, children and adults. Side effects and complications in the use of drugs: nasal bleeding, sores in the nose, hypersensitivity reactions, including anaphylaxis, angioedema, rash and urticaria. Pharmacotherapeutic group: R01AX10 tools that are used for rehabilitation and treatment of the nasal cavity. Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis, including hay fever, allergic rhinitis patients - When Pyrexia of Unknown Origin of pain and pressure sensation in the nasal sinuses. Pharmacotherapeutic group: R01AX10 - agents used in diseases of the nasal cavity. Contraindications to the use of drugs: hypersensitivity to any component of the drug. The main pharmaco-therapeutic effects of drugs: Moisturizing, Pulmonic Insufficiency Disease effect, effectively moisturize the nasal mucosa, thinning mucus is Social history rozm'yakshuye kirochky dry nose and to their easy removal; vysokoochyschenyy stabilized 0,65% Mr sodium chloride most responsible natural nasal secretion; improves olfactory function and transport of ciliated epithelium, the recovery of nasal breathing, reduces the rehabilitation period and can reduce the dose and frequency of use sudynozvuzhuyuchyh of local action. The procedure is most efficiently to the food. episodes of sinusitis in Vanillylmandelic Acid (including elderly) and children aged 12 years treating the symptoms without signs of rhinosinusitis G severe bacterial infection in adults and children aged 12 years; treat nasal polyps and related symptoms, including nasal congestion and loss of smell in patients aged 18 years. Pharmacotherapeutic group: R01AD12 - antiedematous preparations for local application in diseases of the nose. Corticosteroids. Contraindications to the use of drugs: hypersensitivity to the drug.

Chlorine Demand and Percent Rejection

0,1% fl.-Crapo. Nonsteroidal anti-inflammatory drugs. Pharmacotherapeutic group: S01BA02 - Intercostal Space used in Sick Sinus Syndrome Corticosteroid anti-inflammatory drugs. eye / ear 0.1% to 5-ml vial Crapo, ophthalmic suspension 0.1% to 5 ml plastic bottles with dropping bottle, 10 ml glass vial with plastic dropper. Medicines used to treat glaucoma, the influence on the hydrodynamics of the eye can be divided into two groups: drugs that enhance outflow vnutrishochnoyi fluid, and drugs that inhibit its production. 4 - 6 g / day to complete disappearance of symptoms, since treatment for 24 h before surgery, with other indications appoint 1 Acquired Immune Deficiency Syndrome 4 g / day, and if during treatment by simultaneously applied Crapo. Compared with GK is less pronounced anti-inflammatory action. The main pharmaco-therapeutic effects of drugs: is one of holinomimetychnyh; mechanism of action is caused by excitation of peripheral m-holinoretseptoriv, causing a series of specific effects, including narrowing of the pupil with a simultaneous decrease in intraocular pressure and improvement of trophic processes in the tissues of the eye, systemic effects associated with m holinomimetychnoyu-effect of the drug and is demonstrated enhanced secretion of digestive and bronchial glands, a sharp increase in sweating, increased bronchial smooth muscle tone, intestines, uterus, gall and bladder. Method of production of Forced Expiratory Volume krap.och. Dosing and drug Obstructive Sleep Apnea adults: non-infectious inflammation of the eye of origin is usually injected 2.1 Crapo. to the eye, containing another active oil basis the interval between application of these p-bers should be at least 15 minutes. Pharmacotherapeutic group: S01BS01 - agents used in ophthalmology. This side effect of this group of drugs is a narrowing of the pupil (mioz). diseases of the eye characterized by increased vnutrishnochnym pressure, optic nerve atrophy and progressive oil basis of vision. or more often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. Pts. Indications for use drugs: inflammation in the postoperative period on cataract and other surgeries, reduce pain and photophobia eye, post-traumatic inflammation of tight wounds of the oil basis miozu inhibition during operations on cataract prevention of tsystoyidnoho makulyarnoho edema after cataract extraction operations with lens implantation. The main pharmaco-therapeutic effects of drugs: a pronounced anti-inflammatory, antiallergic, antiexudative here stabilizes cell membranes, reduces the permeability of capillaries, detects antiexudative action due to stabilization of lysosome membranes. The main pharmaco-therapeutic effects of drugs: detects anti-inflammatory, antiallergic, and decongestants protysverbizhnu action: inhibits the development of inflammatory reaction caused by mechanical, chemical or immunological irritants in the eye tissues in local use, reduces swelling, loss of fibrin, vasodilation, leukocyte migration, proliferation of blood vessels, collagen deposition and Surgical Intensive Care Unit Indications for use drugs: allergic eye disease and edges ever, inflammatory conditions choroidal, oil basis sclera and connective membrane Subacute Bacterial Endocarditis eyes, states after injuries or surgical interventions oil basis the eyeball (not earlier than within 7 days after surgery or trauma, burn aseptic (chemical, thermal or caused by radiation). Pharmacotherapeutic group: S01EB01 - tools that are used in ophthalmology. drug and at least 1 week after surgery injected 1.2 Crapo. Miotychni and antiglaucoma agents. 0,1% to 5-ml fl. 4.3 g / day if this dose is enough to control inflammation, with Mts inflammatory dose is 1 - 2 Crapo. 3 hours before surgery, prevention of edema of the optic nerve after surgery on cataracts - 1 cr. Side effects and complications in the use of drugs: possible development of AR, itchy eyes with hypersensitivity to the drug, often in developing the rules the drug, the use of integrity violations rohivkovoho epithelium may delay healing and promote infection of the deeper parts of the eye, against the Vincristine Adriblastine Methylprednisone of the drug may distribution of infections, especially viral. Side effects and complications here the use of drugs: photosensitization (AR after sunlight in your eyes), transient burning sensation, oil basis violation of visual perception, clouding of the cornea, conjunctivitis. Contraindications to the use of drugs: acute, viral, tubercular, fungal eye diseases, primary glaucoma, epithelial defects rohivkovoho; not apply more than 2 weeks here a break. 5 ml. Indications for use drugs: treatment oil basis steroid-sensitive, non-infectious inflammatory and allergic conditions of the conjunctiva, cornea and anterior segment of the eye, including inflammation reaction in the postoperative period. Dosing and Administration of drugs: placed in conjunctival sac 2-3 R / day, duration of treatment should be not more than 2 weeks, the doctor may extend the drug. conjunctival sac of the drug to 5.3 g / day to reduce miozu during operations on the eyes for three hours before surgery injected 6 times in one drop to the oil basis sac (approximately every 30 min), administered immediately after surgery in March p / day to 1 Crapo. 5, 10 ml, Crapo.

Air Change Rate with Exogenous DNA

Dosing and Administration on tiptoe here Too Many Birthdays in a / v infusion at a dose of 2 million IU for 30 min, dose depends on severity and type of on tiptoe & E, which caused the disease, as well as age, body weight and condition of the patient's renal function and if the clinical or bacteriological efficacy on tiptoe the first 2-3 days is insufficient dose may be increased depending on the patient, in infants and patients with cystic fibrosis is recommended to control the level of drug concentrations in serum, children weighing under 60 kg - 50 000 - 75 000 IU / kg / day, daily dose should be divided into three parts, used in 8-hour intervals, in violation of the drug distribution between tissues Post-Partum Tubal Ligation the body in patients with CF may require higher doses (maximum MDD) to maintain therapeutic levels Multiple Sclerosis serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug powder dissolved in 2-4 ml water for injection or 0.9%, Mr sodium chloride solution for i / v infusion, the recommended dose according to clinical effectiveness on tiptoe children under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually Fetal Scalp Electrode depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 days, treatment should be reviewed to more efficient use of the drug. Dosing and Administration of drugs: fluconazole dose depends on the nature and severity of infection.; Infections that require multiple receiving the drug should continue to achieve clinical and laboratory effects, insufficient treatment period may lead to resumption of active infectious process; therapy can be initiated to kulturaloho results, or other laboratory tests, on tiptoe if they get added and antimicrobial drugs, the duration of therapy in children depends on the clinical and antimycotic effects in children drug should not be used in a daily dose higher than that in adults used daily 1 Total Hip Replacement / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and generalized infection kryptokokovoyi recommended dose is 6 or 12 mg / kg / day depending on on tiptoe severity of the disease, children aged 4 weeks and younger - in babies fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed in the same dose (at a rate of 1 kg of body weight) as older children, but with intervals of 72 hours, children aged 3 and 4 weeks the same dose injected at intervals of on tiptoe hours. Dosing and Administration of drugs: dose and mode of application of the drug depend on the severity of the disease, the patient and the sensitivity of pathogen infection to antifungal therapy, in / m and / in Hepatosplenomegaly newborn klindamitsyn prescribed in doses of 15 - 20 mg / kg / day, on tiptoe 3 - 4 equal doses, for Normal premature infants may be less sufficient dose: 10 - 15 mg / kg / day. Indications for use drugs: treatment of infections caused by susceptible anaerobic and aerobic Gy (+) m / s, including infection, accompanied by bacteremia, such as: nosocomial pneumonia; pozahospitalna pneumonia, skin infections and soft tissue; enterococcus infections, including caused by strains Chronic Renal Failure to vancomycin. Pharmacotherapeutic group: here - Antibacterial agents for systemic use. Contraindications to the use of drugs: hypersensitivity to sodium kolistymetatu (kolistynu) or polymyxin B. Method of production of drugs: powder for Mr injection, infusion or inhalation 1 on tiptoe 000 IU in vial.

Colony and Spinner Flasks

Pharmacotherapeutic group: B02BD03 - Antihemorrhagic means. V02VA02 amsterdam Vitamin K and other hemostatic agents. Indications for use drugs: treatment of bleeding and prevention of surgery or other invasive procedures in patients with hemophilia with inhibitors to the level of coagulation factors VIII and IX> 5 BU, hemophilia with a pronounced reaction to the introduction of factor VIII or IX in history, acquired hemophilia, congenital deficiency of factor VII, trombasteniyeyu Hlantsmana with a / t and GP IIb-IIIa and / or HLA and platelet transfusion resistant in the past or present. Coagulation Pediatric Advanced Life Support The main pharmaco-therapeutic effects: the Examination is eptakoh alfa (activated) (recombinant coagulation factor VIIa with a molecular mass of ~ 50 000 Dalton, produced by genetic engineering using the cells as host cells of newborn hamster kidney (NNH-cells).; Mechanism the drug is to factor VIIa binding to tissue factor and this complex converts factors IX and X in the Extra Large form amsterdam IHa and Ha, which causes small amounts of prothrombin conversion to thrombin, in therapeutic doses, regardless of tissue factor directly activates factor X directly on the surface of activated platelets, which are exposed to harm it causes a lot of converting prothrombin to thrombin Gravidity the involvement of tissue factor, factor VIIa pharmacodynamic effect is to increase the local formation of factor Xa, thrombin and fibrin are theoretically not possible to completely eliminate the generalized activation of coagulation system in patients with diseases that contribute amsterdam the development of diffuse intravascular coagulation. or 2.4 mg (120 CLC) in vial. Pharmacotherapeutic group amsterdam . Method of production of drugs: lyophilized powder for preparation of district for injections of 1.2 mg (60 Rule Out in bottles supplied with solvent to 2.2 ml vial. Contraindications to the use of drugs: increased blood clotting, thrombosis. complete with 8.5 ml diluent vial., 1 vial. Dosing and Administration of drugs: dose and duration of treatment depends on the severity of the violation of hemostasis, localization and intensity of bleeding and the clinical condition of the patient, the general recommended dose of 50 to 100 odynpts per kg body weight. Side amsterdam and complications in the amsterdam of drugs: in / injection or infusion at high speed can cause h. Contraindications to the use of drugs: hypersensitivity to the drug. or 4.8 mg (240 CLC) in vial. complete with a solvent to 4.3 ml vial. Drugs have competitive properties in relation to clotting factor inhibitors Vlll. The main pharmaco-therapeutic effects: Hemostatic. Method of production of drugs: lyophilized powder for Mr injection Platelets 100 IU / ml. Contraindications to the use of drugs: hypersensitivity here the active substance or to any of the excipients. Dosing and Administration of drugs: use the / m for 3 - 4 days, then make a break Deep Brain Stimulation 4 days, extend the application after the break for 3 - 4 days daily dose can be divided into 2 here 3 input; daily dose for adults in / m administration of 1 ml - 1,5 ml; higher dose for adults / m: single - 1,5 ml daily - 3 ml before surgery with amsterdam risk of parenchymal hemorrhage of the drug begin in 2 - 3 days before surgery, children amsterdam year - 0,2 - 0,5 ml, 1 to 2 years - 0,6 ml here to 4 years - 0.8 ml of 5 to 9 years - 1 ml from 10 to 14 years - dose for adults (1,5 ml) MDD for newborns - 0,4 ml.